Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment.
about
Optimal usage of the GnRH antagonists: a review of the literatureThe effect of cigarette smoking, alcohol consumption and fruit and vegetable consumption on IVF outcomes: a review and presentation of original dataSleep in women undergoing in vitro fertilization: a pilot studyOutcomes and Recommendations of an Indian Expert Panel for Improved Practice in Controlled Ovarian Stimulation for Assisted Reproductive Technology.Prognostic models for high and low ovarian responses in controlled ovarian stimulation using a GnRH antagonist protocolClinical impact of LH rises prior to and during ganirelix treatment started on day 5 or on day 6 of ovarian stimulation.Serum dehydroepiandrosterone sulphate concentration is not a predictive factor in IVF outcomes before the first cycle of GnRH agonist administration in women with normal ovarian reserve.Study of two strategies to induce follicular wave emergence for assisted reproductive treatments (ART)-a preliminary trial.What is the value of anti-Müllerian hormone in predicting the response to ovarian stimulation with GnRH agonist and antagonist protocols?Progesterone elevation on the day of human chorionic gonadotropin administration adversely affects the outcome of IVF with transferred embryos at different developmental stages.Measurement of antral follicle count in patients undergoing in vitro fertilization treatment: results of a worldwide web-based survey.Predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles.Comparison of the GnRH agonist and antagonist protocol on the same patients in assisted reproduction during controlled ovarian stimulation cycles.How Much Does AMH Really Vary in Normal Women?Ovarian response prediction in controlled ovarian stimulation for IVF using anti-Müllerian hormone in Chinese women: A retrospective cohort study.Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response.Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques.Effect of metformin and oral contraceptives on polycystic ovary syndrome and IVF cycles.Baseline AMH Level Associated With Ovulation Following Ovulation Induction in Women With Polycystic Ovary Syndrome.High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol.Inositol supplement improves clinical pregnancy rate in infertile women undergoing ovulation induction for ICSI or IVF-ET.Melatonin concentration in follicular fluid is correlated with antral follicle count (AFC) and in vitro fertilization (IVF) outcomes in women undergoing assisted reproductive technology (ART) procedures.Effect of deslorelin acetate treatment in oocyte recovery and in vitro embryo production in domestic cats.The use of serum anti-Mullerian hormone (AMH) levels and antral follicle count (AFC) to predict the number of oocytes collected and availability of embryos for cryopreservation in IVF.Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone.Follicular and endocrine dose responses according to anti-Müllerian hormone levels in IVF patients treated with a novel human recombinant FSH (FE 999049).Evaluation of ovarian reserve in women with overt or subclinical hypothyroidism.Endometriosis and ART: A prior history of surgery for OMA is associated with a poor ovarian response to hyperstimulation
P2860
Q21245566-7A9E5057-F495-41A5-AA1D-3D0436ACAA7FQ28082495-D8553602-6872-4594-9FA1-D8FD82B29D7AQ29248917-F9833EF1-4181-4024-BFF8-E946DC0C4973Q30399240-8A098258-6643-4014-80C9-1215BE866B27Q33888265-DDBE1607-685C-4A74-8DD3-6CE8FFA5033FQ34656033-ED650DA4-831D-437D-ADEC-38832AAB1A57Q35148124-DB4CFD6C-FD3A-4AE9-8A10-B40117EAF2AAQ35236614-80B87574-EBA4-4ADA-89E0-68691CEE8D7AQ35750252-10111643-3F4F-4F03-BB46-543C4411A375Q35914715-6DC540C4-7300-4363-B661-DC4BF04D13DDQ36192094-20D5CA99-48E7-4829-976A-2FE34B5E6FCBQ36234933-8D87B5F7-81E3-4C74-AE50-8CF5D61541D2Q37138027-F98A89A3-BE41-494D-A5C3-00884F6F7111Q37367598-EFE700E9-944B-40B3-88E9-F604838525A3Q37737306-7066A3EA-5D18-4565-AB30-D14CC9BDAB5FQ38285639-0ADBB19A-0AA5-4570-B467-387E776CDA49Q38765739-EE39B8DF-B0B7-49F3-ABB2-24DE110B417AQ38937980-57319424-5F52-4426-B5ED-C6943BD96A82Q39734053-E18F7F06-5671-4048-A825-605FCD0A2145Q44395927-D2A0BE7D-DA95-4E73-A56F-1E7C9FBB948EQ48505844-AEEEE3D4-7A33-4C39-B441-911BECA72068Q48507223-FA52B46C-00D0-472E-A09D-86691E177428Q48534595-E88DA61D-258B-486E-BFB9-B360417BABB3Q48545469-CB03B961-59A2-4286-B6AE-39F291704D1CQ48592002-4BC9C289-6A92-4BAA-9D0E-70C0B4F6B4C5Q49171172-C315985D-BC4D-4B75-B1F1-16847EB28B1CQ54919324-7FD00181-5FCE-47B5-986F-5FE1C288D8E8Q58765683-659D177B-5112-4F1B-A4AA-E9220C4F1186
P2860
Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Predictive factors of ovarian ...... l contraceptive pre-treatment.
@en
Predictive factors of ovarian ...... l contraceptive pre-treatment.
@nl
type
label
Predictive factors of ovarian ...... l contraceptive pre-treatment.
@en
Predictive factors of ovarian ...... l contraceptive pre-treatment.
@nl
prefLabel
Predictive factors of ovarian ...... l contraceptive pre-treatment.
@en
Predictive factors of ovarian ...... l contraceptive pre-treatment.
@nl
P2093
P2860
P356
P1433
P1476
Predictive factors of ovarian ...... l contraceptive pre-treatment.
@en
P2093
A Nyboe Andersen
B Mannaerts
Xpect investigators
P2860
P304
P356
10.1093/HUMREP/DER318
P407
P577
2011-09-27T00:00:00Z